These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34680929)

  • 1. Immune Profiling of Medullary Thyroid Cancer-An Opportunity for Immunotherapy.
    Hińcza-Nowak K; Kowalik A; Walczyk A; Pałyga I; Gąsior-Perczak D; Płusa A; Kopczyński J; Chrapek M; Góźdź S; Kowalska A
    Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer.
    Hińcza-Nowak K; Kowalik A; Walczyk A; Pałyga I; Gąsior-Perczak D; Płusa A; Kopczyński J; Chrapek M; Góźdź S; Kowalska A
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case Report of Sequential Use of a Yeast-CEA Therapeutic Cancer Vaccine and Anti-PD-L1 Inhibitor in Metastatic Medullary Thyroid Cancer.
    Del Rivero J; Donahue RN; Marté JL; Gramza AW; Bilusic M; Rauckhorst M; Cordes L; Merino MJ; Dahut WL; Schlom J; Gulley JL; Madan RA
    Front Endocrinol (Lausanne); 2020; 11():490. PubMed ID: 32849281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Immune Profiling of Medullary Thyroid Cancer.
    Pozdeyev N; Erickson TA; Zhang L; Ellison K; Rivard CJ; Sams S; Hirsch FR; Haugen BR; French JD
    Thyroid; 2020 Sep; 30(9):1263-1279. PubMed ID: 32242507
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulatory Role of Single Nucleotide Polymorphisms of Distinct Genetic Pathways on Clinical Behavior of Medullary Thyroid Carcinoma.
    Mishra V; Kowtal P; Rane P; Sarin R
    Asian Pac J Cancer Prev; 2020 May; 21(5):1289-1293. PubMed ID: 32458635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics in Medullary Thyroid Cancer: From Pathogenesis to Targeted Therapy.
    Vitale G; Dicitore A; Messina E; Sciammarella C; Faggiano A; Colao A
    Recent Pat Anticancer Drug Discov; 2016; 11(3):275-82. PubMed ID: 27306881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Proteomics Analysis of Sporadic Medullary Thyroid Cancer Reveals FN1 as a Potential Novel Candidate Prognostic Biomarker.
    Zhan S; Li J; Wang T; Ge W
    Oncologist; 2018 Dec; 23(12):1415-1425. PubMed ID: 29739896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sorafenib in Japanese Patients with Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma.
    Ito Y; Onoda N; Ito KI; Sugitani I; Takahashi S; Yamaguchi I; Kabu K; Tsukada K
    Thyroid; 2017 Sep; 27(9):1142-1148. PubMed ID: 28635560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine-needle aspiration cytology for medullary thyroid carcinoma: a single institutional experience in Japan.
    Suzuki A; Hirokawa M; Takada N; Higuchi M; Ito A; Yamao N; Hayashi T; Kuma S; Miyauchi A
    Endocr J; 2017 Nov; 64(11):1099-1104. PubMed ID: 28883261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathology of C Cells and Medullary Thyroid Carcinoma.
    Schmid KW
    Recent Results Cancer Res; 2015; 204():41-60. PubMed ID: 26494383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surufatinib in Chinese Patients with Locally Advanced or Metastatic Differentiated Thyroid Cancer and Medullary Thyroid Cancer: A Multicenter, Open-Label, Phase II Trial.
    Chen J; Ji Q; Bai C; Zheng X; Zhang Y; Shi F; Li X; Tang P; Xu Z; Huang R; Huang T; Pan Y; Fan S; Zhou J; Su W
    Thyroid; 2020 Sep; 30(9):1245-1253. PubMed ID: 32075524
    [No Abstract]   [Full Text] [Related]  

  • 12. [Medullary thyroid carcinoma].
    Tiedje V; Ting S; Dralle H; Schmid KW; Führer D
    Internist (Berl); 2015 Sep; 56(9):1019-31. PubMed ID: 26338063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma.
    Werner TA; Forster CM; Dizdar L; Verde PE; Raba K; Schott M; Knoefel WT; Krieg A
    Br J Cancer; 2017 Dec; 117(12):1837-1845. PubMed ID: 29112684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of PD-L1 in medullary thyroid carcinoma-a new therapeutic target?
    Fonseca L; Freitas C; Caramelo A; Eloy C
    Endocrinol Diabetes Metab; 2021 Jul; 4(3):e00241. PubMed ID: 34277966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging.
    Smith A; Galli M; Piga I; Denti V; Stella M; Chinello C; Fusco N; Leni D; Manzoni M; Roversi G; Garancini M; Pincelli AI; Cimino V; Capitoli G; Magni F; Pagni F
    J Proteomics; 2019 Jan; 191():114-123. PubMed ID: 29581064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of integrin α
    de Vries LH; Lodewijk L; Pijnappel EW; van Diest PJ; Schepers A; Bonenkamp HJ; van Engen-van Grunsven IA; Kruijff S; van Hemel BM; Links TP; Nieveen van Dijkum EJ; van Eeden S; van Leeuwaarde RS; Valk GD; de Keizer B; Borel Rinkes IH; Vriens MR
    Future Oncol; 2024; 20(27):2015-2022. PubMed ID: 39101553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procalcitonin: A New Biomarker for Medullary Thyroid Cancer? A Systematic Review.
    Karagiannis AK; Girio-Fragkoulakis C; Nakouti T
    Anticancer Res; 2016 Aug; 36(8):3803-10. PubMed ID: 27466480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurotransmitter calcitonin gene-related peptide shapes an immunosuppressive microenvironment in medullary thyroid cancer.
    Hou Y; Lin B; Xu T; Jiang J; Luo S; Chen W; Chen X; Wang Y; Liao G; Wang J; Zhang J; Li X; Xiang X; Xie Y; Wang J; Peng S; Lv W; Liu Y; Xiao H
    Nat Commun; 2024 Jul; 15(1):5555. PubMed ID: 39030177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of fine-needle aspirate calcitonin to detect medullary thyroid carcinoma: A systematic review.
    Trimboli P; Guidobaldi L; Bongiovanni M; Crescenzi A; Alevizaki M; Giovanella L
    Diagn Cytopathol; 2016 Jan; 44(1):45-51. PubMed ID: 26481456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Medullary Thyroid Cancer.
    Viola D; Elisei R
    Endocrinol Metab Clin North Am; 2019 Mar; 48(1):285-301. PubMed ID: 30717909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.